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A case of emphysematous hepatitis with spontaneous 
pneumoperitoneum in a patient with hilar 
cholangiocarcinoma
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Ju Hyun Kim, and Yeon Suk Kim
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Incheon, Korea
An 80-year-old woman with hilar cholangiocarcinoma was hospitalized due to sudden-onset abdominal pain. Computed 
tomography revealed hepatic necrosis accompanied with emphysematous change in the superior segment of the right 
liver (S7/S8), implying spontaneous rupture, based on the presence of perihepatic free air. Although urgent percutaneous 
drainage was performed, neither pus nor fluids were drained. These findings suggest emphysematous hepatitis with a 
hepatic mass. Despite the application of intensive care, the patient’s condition deteriorated rapidly, and she died 
3 days after admission to hospital. Liver gas has been reported in some clinical diseases (e.g., liver abscess) to be 
caused by gas-forming organisms; however, emphysematous hepatitis simulating emphysematous pyelonephritis is very 
rare. The case reported here was of fatal emphysematous hepatitis in a patient with hilar cholangiocarcinoma. (Korean J 
Hepatol 2012;18:94-97)
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INTRODUCTION
Emphysematous change in the liver can be seen in several 
clinical situations, such as liver abscesses caused by gas- 
forming bacteria, after sphincterotomy, and bowel infar-
ction.
1-3 Hepatic artery thrombosis after liver transplantation 
can sometimes lead to gas gangrene of the liver.
4,5 Except for 
these incidental cases, there have been few reports of hepatic 
parenchymal emphysematous change. Futhermore, clinical 
outcome is reported to be very poor despite application of 
aggressive management. Radiologically, the features are 
similar to those of emphysematous pyelonephritis.
6 We 
recently experienced an extremely rare case of emphyse-
matous hepatitis accompanied in a patient with hilar 
cholangiocarcinoma.
CASE REPORT
An 80-year-old woman was admitted to Gachon Gil 
Medical Center due to severe right upper quadrant (RUQ) 
abdominal pain of 2 days, before which she had been 
diagnosed as hilar cholangiocarcinoma (Fig. 1). An endo-
scopic retrograde biliary stent was placed for biliary drain-
age 2 months prior to the current admission. She had no 
medical history, such as diabetes mellitus or biliary 
surgery. Symptoms related to cholangitis were resolved 
with biliary stenting and her general condition showed 
improvement. Because of her refusal to undergo surgical 
treatment, radiotherapy was applied after palliative biliary 
stenting. Computed tomography (CT) performed for simu-
lating a radiation therapy taken 17 days prior to admission Jung Ho Kim, et al. Rare case of emphysematous hepatitits  95
 
Figure 1. Computed tomography (CT) and magnetic resonance imaging (MRI) findings on initial diagnosis. (A) Coronal contrast- 
enhanced CT scan showing ductal wall thickening with enhancement in the hilar portion of the extrahepatic bile duct (black arrow). 
Dilatation of the right intrahepatic bile duct without separation of the second-order branch of the right intrahepatic duct was noted, 
suggesting a type IIIa Klatskin tumor. (B) Magnetic resonance cholangiopancreatography (MRCP) demonstrated severe narrowing of 
both common hepatic ducts and the right first-order intrahepatic duct (white arrow), with marked dilatation of the right intrahepatic 
duct, as seen on CT.
Figure 2. CT performed for simulating radiation therapy. Axial 
contrast-enhanced CT scan revealing dilatation of the right 
intrahepatic bile duct without separation of the second-order 
branch of the right intrahepatic duct. There was no evidence of 
liver infection. Endoscopic retrograde biliary drainage is also 
visible (black arrow).
revealed ideal placement of an endoscopic retrograde biliary 
drainage stent (Fig. 2). She received 9 times of radiotherapy 
with a total dose of 16.2 Gy (1.8 Gy×9 fractions).
On admission, she was conscious and acutely ill in 
appearance. Her vital signs included a temperature of 
36.7℃, a heart rate of 100 beats/min, a blood pressure of 
120/70 mmHg, a respiratory rate of 18 breaths/min, and an 
oxygen saturation of 94% on room air. Her sclera was icteric 
and her liver was palpable approximately 2 cm below the 
right costal margin. Right upper quadrant tenderness of the 
abdomen was present. The spleen was not palpable. Initial 
complete blood count showed a white blood cell count of 
36,130 mm
3, hematocrit of 28.2%, and hemoglobin of 9.3 
mg/dL. Blood urea nitrogen was 34.9 mg/dL and creatinine 
was 1.4 mg/dL. C-reactive protein was 26.56 mg/dL. On 
liver function tests, aspartate transaminase of 882 IU/L, 
alanine transaminase of 257 IU/L, alkaline phosphatase of 
464 IU/L, and total bilirubin of 17.9 mg/dL. Prothrombin 
time was normal. Abdominal CT scan demonstrated hepatic 
parenchymal emphysema measuring approximately 6.3×4.4 
cm in the superior segment of the right liver (S7/S8) with 
pneumoperitoneum finding in the perihepatic space (Fig. 3). 
Urgent percutaneous drainage was attempted under the 
peritonitis impression; however, no fluid was drained. A 
diagnosis of emphysematous hepatitis with spontaneous 
rupture into the peritoneal cavity was made.
On the second day of admission, aggravated laboratory 
tests were noted as follows: WBC 26,000 mm
3, aspartate 
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Figure 3. Contrast-enhanced CT scan images taken on emergent admission. (A) Horizontal section. A contrast-enhanced CT scan of 
the upper abdomen demonstrating hepatic necrosis with emphysematous change (open arrow)-a totally emphysematous lesion in the 
right lobe of the liver. (B) Coronal section. CT scan showing pneumoperitoneum in the perihepatic space (white arrows). The black 
arrow shows an endoscopic retrograde biliary drainage tube.
transaminase 978 IU/L, alanine transaminase 257 IU/L, 
alkaline phosphatase 367 IU/L, total bilirubin 27.4 mg/dL, 
blood urea nitrogen 50.2 mg/dL, creatitine 1.2 mg/dL, 
prothrombin time INR 1.19. Clostridium perfringens and 
Escherichia coli were grown on blood culture. She was 
empirically treated with cefotaxime and metronidazol. 
Despite intensive therapy in the ICU, the patient’s condition 
did not show improvement and she expired on the third day 
of admission.
DISCUSSION
Intra-abdominal emphysematous infections have not been 
uncommonly found in many organs, including the urinary 
tract, gallbladder, uterus, stomach, and pancreas
1; however, 
a few have been found in the liver or biliary system. In liver, 
emphysematous condition can be seen in pyogenic liver 
abscesses by gas-forming abscess or after invasive procedures, 
such as transarterial embolization, radiofrequency ablation, 
and percutaneous ethanol injection in hepatocellular 
carcinoma,
2,3,7,8 of which cases have been seen only in the 
portion of the affected lesion. Therefore, emphysematous 
replacement of a liver is an extremely rare clinical condition.
The usual CT finding of pyogenic liver abscess is clustered 
or multi-septated lesion with fluid collection of surrounding 
parenchymal edema.
6,9,10 In few cases of gas-forming pyogenic 
liver abscess, air bubbles or an air-fluid level can be revealed 
with localization in the involved area. On the other hand, in 
our case, the affected liver was totally replaced by air with 
no fluid content.
Another differentiating disease, gas gangrene in the liver, 
which requires compromise of the both hepatic arterial and 
portal venous supplies, has been reported in the clinical 
setting of hepatic trauma or liver transplantation.
4,5,11,12 
Although parenchymal gas bubbles can be found in these 
conditions, like our case, parenchymal necrosis with 
emphysematous change is not feasible and pneumobilia is 
usually accompanied in cases of gas gangrene. Since both 
hepatic artery and portal veins were patent on CT scan and 
there was no history of diabetes mellitus and atherosclerosis, 
differentiation is easily possible.
In addition, our case differs from radiation induced liver 
disease (RILD). RILD, often called radiation hepatitis, 
typically occur between 2 weeks to 3 months after therapy.
13 
Broad guidelines for normal liver dose constraints, for 
5% or less risk of RILD, is a whole liver dose of 28-30 Gy in 
2 Gy per fraction or a mean normal liver dose (liver minus 
gross tumor volume) of 28-32 Gy in 2 Gy per fractions.
14 
The CT findings that favor RILD were seen in areas of low 
attenuation resulting from either edema or vascular 
congestion in the target volume that corresponded to the 
irradiated portion of the liver, a sharp line of demarcation 
corresponding to the external beam port, usually with an 
anteroposterior or oblique orientation.
15 Our patient received 
a total dose of 16.2 Gy in 1.8 Gy per fraction and a mean 
normal liver dose of 6.0 Gy. The last radiation therapy was 
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administrated in the hospital three days ago. In this regard, 
the possibility of RILD in our case is very rare.
Of particular interest, spontaneous pneumoperitoneum 
caused by ruptured hepatic lesions in this case was observed 
in the perihepatic space. Spontaneous pneumoperitoneum of 
infection in an intra-abdominal organ is extremely rare, and 
only a few cases have been reported.
16
As mentioned in another report, emphysematous hepatitis 
is similar to the findings of emphysematous pyeolonephritis.
6 
Empysematous pyelonephritis is classified into two subtypes 
(types I and II) according to findings on CT scan.
17,18 Type I 
emphysematous pyelonephritis refers to renal parenchymal 
necrosis with either absence of fluid content or the presence 
of a streaky or mottled gas pattern and type II refers to the 
presence of renal or perirenal fluid accompanied by a bubbly 
gas pattern or gas in the collecting system.
17,18 Considering 
these findings, our case appears to be equivalent to type I 
emphysematous pyelonephritis and we can diagnose as 
emphysematous hepatitis.
Late stent blockage by biliary sludge is a major 
complication. In one study, adherence of Clostrium sp. to the 
stent occurred as few as 6 days after stent placement and the 
bacterial density appeared to be proportional to the length of 
time the stent remained.
19 However, the authors reported that 
though few enrolled patients had symptoms of fever, pain, 
and leukocytosis at the time of stent removal, most of the 
patients in their study had no clinical symptoms of biliary 
infection. Inhibition of growth of Clostridium perfringens 
by bile acids has been reported.
20 In another study of patients 
who received chemotherapy with a biliary stent, the 
incidence of stent related complications, such as infection 
and stent blockage, was not significant.
21 Therefore, it is our 
cautious conclusion that the role of the biliary stent in this 
case may be very limited.
The clinical outcome of emphysematous hepatitis 
appears to be fatal, as seen in our case and in other reports.
6 
Therefore, an aggressive therapeutic modality is emphasized 
and surgical intervention should not be delayed in patients 
with emphysematous hepatitis who do not show substantial 
improvement after intensive medical therapy. Unfortunately, 
in our case, the rapidly aggravating condition did not 
provide an opportunity for rescue. In conclusion, we have 
described a very rare case of emphysematous hepatitis 
featuring total emphysematous replacement of hepatic 
prarenchyme, leading to death.
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